Sign in

CIK 0001517022

  • Large accelerated filer

Akebia Therapeutics, Inc.

Sign in to watch
Ticker
AKBA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
208756903
Phone
+1 617-871-2098
Business address
180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
  1. 4 Open-market sale SVP, General Counsel, Sec. sold 1,484 shares at $9.54 ($14,160)
  2. 4/A Open-market sale SVP, General Counsel, Sec. sold 1,483 shares at $9.09 ($13,478)
  3. 4/A Open-market sale SVP, General Counsel, Sec. sold 1,715 shares at $11.46 ($19,655)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4/A Open-market sale Director sold 996 shares at $9.09 ($9,052)
  12. 4/A Open-market sale Director sold 995 shares at $11.46 ($11,403)
  13. 4/A Open-market sale Director sold 11,933 shares at an average $11.23 ($134,035)
  14. 4 Exercise or conversion CEO and President acquired 50,000 shares (option exercise)
  15. 4 Open-market buy Director bought 420,000 shares at $8.25 ($3,465,000)
  16. 4 Open-market sale Director sold 996 shares at $9.09 ($9,052)
  17. 4 Open-market sale SVP, General Counsel, Sec. sold 1,483 shares at $9.09 ($13,478)
  18. 4 Exercise or conversion CEO and President acquired 100,000 shares (option exercise)
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 16 of 19 · 378 filings